世界中医药
文章摘要
引用本文:陈金田1,周鑫1,2,李建华1,朱清广1,2,单一鸣1,房敏1,2,3,孙武权1.推拿联合塞来昔布治疗腰椎间盘突出症的疗效观察[J].世界中医药,2024,(10):.  
推拿联合塞来昔布治疗腰椎间盘突出症的疗效观察
Clinical Effect of Tuina Combined with Celecoxib on Lumbar Disc Herniation
投稿时间:2022-08-01  
DOI:10.3969/j.issn.1673-7202.2024.10.014
中文关键词:  腰椎间盘突出症  推拿  塞来昔布  疼痛评分  功能障碍指数  临床疗效
English Keywords:Lumbar disc herniation  Tuina  Celecoxib  Pain score  Oswestry Disability Index(ODI)  Clinical effect
基金项目:国家自然科学基金项目(81874512)——推拿(扌衮)法关节和肌肉运动生物力学特征及工效学研究;上海市中医药循证能力建设项目(2020-XZZX-TN001)——基于腰椎关键肌群力学特征的推拿手法联合塞来昔布治疗腰椎间盘突出症的临床研究;上海市临床重点专科建设项目(Shslczdzk04001)
作者单位
陈金田1,周鑫1,2,李建华1,朱清广1,2,单一鸣1,房敏1,2,3,孙武权1 1 上海中医药大学附属岳阳中西医结合医院上海200437 2 上海市中医药研究院推拿研究所上海200437 3 上海中医药大学附属曙光医院上海201203 
摘要点击次数: 333
全文下载次数: 0
中文摘要:
      目的:观察推拿手法联合塞来昔布治疗腰椎间盘突出症的临床疗效,为临床应用提供可靠循证医学证据。方法:选取2021年3月至2022年1月上海中医药大学附属岳阳中西医结合医院推拿科就诊的腰椎间盘突出症患者80例作为研究对象,按照随机数字表法随机分为观察组和对照组,每组40例。观察组采用推拿联合塞来昔布治疗;对照组单纯口服塞来昔布治疗,干预周期为4周。测量的结果变量包括视觉模拟评分(VAS)、简化McGill疼痛问卷简表(SF-MPQ)和Oswestry残疾指数(ODI)。结果:观察组有效率显著高于对照组(P<0.01);2组都能显著降低患者疼痛评分(P<0.001),但观察组疗效更优(P<0.001);2组都能显著降低患者ODI功能障碍指数(P<0.01),观察组疗效更优(P<0.01)。结论:推拿手法结合塞来昔布治疗腰椎间盘突出症在缓解腰部疼痛、改善腰椎功能方面,优于单纯口服塞来昔布治疗。
English Summary:
      To observe the clinical effect of Tuina combined with celecoxib on lumbar disc herniation and provide reliable medical evidence for clinical application.Methods:Eighty patients with lumbar disc herniation treated in the Department of Tuina in the Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine from March 2021 to January 2022 were randomized into an observation group(n=40) and a control group(n=40).The observation group was treated with Tuina combined with celecoxib,and the control group was treated with oral celecoxib alone.The treatment in both groups lasted for 4 weeks.Outcome variables measured included the Visual Analog Scale(VAS) score,the Short-Form McGill Pain Questionnaire(SF-MPQ) score,and the Oswestry Disability Index(ODI).Results:The response rate of the observation group was higher than that of the control group(P<0.01).Both the observation group and the control group showed decreased VAS and SF-MPQ scores after treatment(P<0.001),and the decreases were more significant in the observation group than in the control group(P<0.001).The ODI declined after treatment in both groups(P<0.01),especially in the observation group(P<0.01).Conclusion:Tuina combined with celecoxib is superior to oral celecoxib alone in relieving lumbar pain and improving the lumbar function in the patients with lumbar disc herniation.
查看全文  查看/发表评论  下载PDF阅读器